
±¸Á¶½ÉÁúȯ ¸Å´º¾ó
- ÀúÀÚ(±Û)±¸Á¶½ÉÁúȯ¿¬±¸È¸
- ÃâÆÇ»ç¸ÞµðÄÿ¡µàÄÉÀ̼Ç
- ¹ßÇàÀÏ2020³â
º´¿øÀÇ 60ºÐ³» ÀÀ±ÞÁø·á½Ã½ºÅÛÀ» ±¸Ãà
°í´ë¾È¾Ïº´¿ø ÈäÅëŬ¸®´ÐÀº ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ µµÂø ÈÄ 60ºÐ À̳»¿¡ Ä¡·áÇÒ ¼ö ÀÖ´Â ÀÀ±ÞÁø·á ½Ã½ºÅÛÀ» ±¸ÃàÇß´Ù.
ÀÌ Á߽ɿ¡ ÀÓ ±³¼ö°¡ ÀÖ´Ù. ÀÓ ±³¼ö´Â ½ÉÀå°Ç°À» ÁöŰ´Â ¹æ¹ýÀº ´Ù¸¥ »ç¶÷À» ¹Ý¸é±³»ç(ÚãØüÎçÞÔ)·Î »ï´Â °ÍÀÌ °¡Àå È¿°úÀûÀ̶ó°í »ý°¢ÇÑ´Ù. ȯÀÚ ¼ö±â¸¦ ¿«Àº Ã¥ '½ÉÀå¿¡°Ô ¸» °É±â', ȯÀÚ »ç·Ê¸¦ ±âÃÊ·Î ¸¸µç ¸¸È '°¡½¿ÀÌ ¾ÆÆÄ¿ä', °Ç° ½Ä»ýȰÀ» °Á¶ÇÑ ¿ä¸®Ã¥ '3Àú¹ä»ó' µîÀ» ÁýÇÊÇÑ ÀÌÀ¯À̱⵵ ÇÏ´Ù.
Á¦ ¸ñ | ½ÉÀåÀçȰÀ» À§ÇÑ ¿îµ¿°ú »ýȰ¿ä¹ý | ||
---|---|---|---|
ÃâÆÇ»ç | °í·Á´ëÇб³ÃâÆÇºÎ | ¹ßÇàÀÏ | 2013³â |
Á¦ ¸ñ | 3î¸(Àú) ¹ä»ó | ||
---|---|---|---|
ÃâÆÇ»ç | ±×¸®°íÃ¥ | ¹ßÇàÀÏ | 2013³â |
Á¦ ¸ñ | [SCI]Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2020. 03 | ¹ßÇ¥Áö | CIRCULATION-CARDIOVASCULAR INTERVENTIONS |
Á¦ ¸ñ | [SCI]Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention with Current-Generation Drug-Eluting Stent | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2020. 02 | ¹ßÇ¥Áö | CIRCULATION: CARDIOVASCULAR INTERVENTIONS |
Á¦ ¸ñ | [SCI]A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2020. 02 | ¹ßÇ¥Áö | BMC CARDIOVASCULAR DISORDERS |
Á¦ ¸ñ | [SCI]Modulating cardiomyocyte and fibroblast interaction using layer-by-layer deposition facilitates synchronisation of cardiac macro tissues | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2020. 01 | ¹ßÇ¥Áö | SOFT MATTER |
Á¦ ¸ñ | [SCI]Cardioprotective effects of genetically engineered cardiac stem cells by spheroid formation on ischemic cardiomyocytes | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2020. 01 | ¹ßÇ¥Áö | MOLECULAR MEDICINE |
½É±Ù°æ»öÁõ Àç»ý ´ëÇѹα¹ ÀÇÇÐÇѸ²¿ø Á¤È¸¿ø ¼¿ï½Ã ´ë»çÁõÈıº Áö¿ø»ç¾÷´Ü´ÜÀå
°¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â ȯÀÚÀÇ ¾ÈÀü°ú °Ç°À» ¿ì¼±À¸·Î ÇÏ´Â °ÍÀÔ´Ï´Ù. ȯÀÚ¸¶´Ù °³º°ÀûÀ¸·Î ÀǰßÀ» Á¸ÁßÇϰí Á¤È®ÇÑ Áø´ÜÀ» ³»·Á¼ ÃÖ»óÀÇ Ä¡·á °á°ú¸¦ À̲ø¾î³»·Á°í ÇÕ´Ï´Ù.
°Ç°À» ÀÒÀ¸¸é ¸ðµç °ÍÀ» ÀÒ´Â °Í°ú °°´Ù°í ÇÕ´Ï´Ù. ±×·¯ÇÏ¿© ´Ê±âÀü¿¡ Á¤±âÀûÀÎ °ËÁøÀ» ÅëÇÏ¿© ÁÖ±âÀûÀ¸·Î »óŸ¦ üũÇϰí, °Ç°ÇÑ ½Ä½À°ü ¹× ¿îµ¿ µî °Ç°ÇÑ »ýȰ½À°üÀ» °¡Áö´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.
°í·Á´ëÇб³ ¾È¾Ïº´¿øÀº 1056º´»ó ±Ô¸ð¸¦ °®Ãá »ó±ÞÁ¾ÇÕº´¿øÀ¸·Î¼ ÁßÁõ ¹× ±Þ¼º±â ÁúȯÀ» Áß½ÉÀ¸·Î ´Ù¾çÇÑ Æ¯¼ºÈ¼¾Å͸¦ ¿î¿µÇϰí ÀÖ´Ù. º´¿ø Àü¹Ý¿¡ ½º¸¶Æ® ÇコÄÉ¾î ½Ã½ºÅÛÀ» µµÀÔÇØ º¸´Ù Á¤È®ÇÏ°í ¾ÈÀüÇÑ ÀǷἺñ½º¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, ±¹°¡ÁöÁ¤ ¿¬±¸Á߽ɺ´¿øÀ¸·Î ¿¬¼Ó ÁöÁ¤µÇ´Â µî ¿¬±¸ ¿ª·®ÀÇ ¿ì¼ö¼ºÀ» ÀÎÁ¤¹Þ°í ÀÖ´Ù.
¼¿ïƯº°½Ã ¼ººÏ±¸ °í·Á´ë·Î 73 °í·Á´ëÇб³ ¾È¾Ïº´¿ø